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Abstract
Rationale:Gastrointestinal multiple metastases of lung cancer are extremely rare. The majority of gastrointestinal metastasis cases
are diagnosed at a late stage and the prognosis is extremely poor. This report describes the clinical characteristics and outcomes of a
patient with gastrointestinal multiple metastases from squamous-cell lung cancer, with special emphasis on the diagnosis and
treatment of metastatic lung cancer.
Patient concerns: A 61-year-old man who presented with progressive abdominal distention was admitted to our hospital.
Radiological examinations showed changes of post-primary pulmonary tuberculosis and mechanical obstruction of the small bowl.
Histopathological ﬁndings of gastroscopic examination and biopsy specimens showed a diagnosis of squamous-cell carcinoma in
the body of the stomach.
Diagnoses: Postoperative histopathology conﬁrmed a gastrointestinal multiple squamous-cell carcinoma in stomach and small
bowl. Finally, squamous-cell lung cancer was conﬁrmed by lung biopsy.
Interventions: During his hospitalization urgent surgery was performed because of acute abdomen. The patient underwent a
laparotomy with curative gastrectomy for gastric cancer and small bowel partial resection. The patient was recommended with
combination chemotherapy of carboplatin and paclitaxel for 3 cycles.
Outcomes: Six months later after operation, the patient succumbed to respiratory failure.
Lessons:We searched the related literature of gastrointestinal metastases from lung cancer and the clinical presentation, site of
metastasis, diagnosis, treatment, and survival time in these cases were reviewed. The present study may increase the awareness of
early diagnosis and appropriate treatment of metastatic lung cancer of gastrointestinal tract.
Abbreviations: AFP = a-fetoprotein, CA = carcinoma antigen, CEA = carcinoembryonic antigen, CT = computerized
tomography, RBC = red blood cell, WBC = White blood cell.
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Lung cancer is considered one of the most commonly diagnosed
cancers, which ranks the leading cause of cancer death amongmen
and the second leading cause of cancer death among women
worldwide.[1] The incidence of lung cancer is high in bothEditor: N/A.
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1developing and developed countries, reﬂecting a prevalence of risk
factors, including smoking and other environmental risk expo-
sures.[1,2] Metastasis is a ﬁnal stage of tumor progression and the
majority of lung cancer patients suffered frommetastatic disease at
diagnosis. Metastasis through blood vessels is the common route
for lung cancer and the liver, adrenal glands, brain, and bones are
the most common sites.[3] Gastrointestinal tract is not a common
site formetastasis of lung cancer and often goes undiagnosed in the
clinical follow up of cancer patients.[4,5] Due to near symptomless
progression, the majority of gastrointestinal metastasis cases are
diagnosed at a late stage, of which the prognosis is extremely
poor.[6] Early diagnosis and treatment of these cases are vital for
their improving survival. Moreover, gastrointestinal multiple
metastases of lung cancer have rarely been reported.
In the present study, the clinical characteristics and outcomes
of a patient with gastrointestinal multiple metastases from
squamous-cell lung cancer were reported. In addition, the clinical
presentation, site of metastasis, diagnosis, treatment, and survival
time in these cases were also reviewed. The present study may
increase the awareness of early diagnosis and appropriate
treatment of metastatic lung cancer of gastrointestinal tract.
This study was approved by the Ethics Committee of the 2nd
Hospital of Jilin University. Written informed consent was
obtained from the patient.
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A 61-year-old man who presented with progressive abdominal
distention for 8 days was admitted to a local hospital on Feb 23,
2014. Gastroscopic examination and biopsy specimens were
evaluated in the local hospital. Histopathological ﬁndings
showed a suspected diagnosis of squamous-cell carcinoma in
the body of the stomach.
On Feb 27, 2014, the patient was transferred to our hospital
for further management strategy. Physical examination showed
that right upper quadrant pain and tenderness were present and
no peristaltic waves. The rest of the physical was unremarkable.
A detailed medical history was obtained. The patient lost weight
of 3kg in recent 1 month. He had been previously admitted to the
hospital for active tuberculosis 5 years ago and ﬁnally recovered
completely. No history of diabetes, coronary artery diseases,
hypertension, hepatitis, drug allergy, previous trauma, or
operation was demonstrated. Laboratory tests revealed the
following: red blood cell (RBC) count, 4.181012/L (normal
range, 3.68–5.131012/L); hemoglobin concentration, 137g/L
(normal range, 114–151g/L); white blood cell (WBC) count,
11.5109/L (normal range, 4–101012/L); platelet count,
289109/L (normal range, 100–300109/L). Tumor markers
were detected as the following: a-fetoprotein (AFP), 3.60ng/mL
(normal range, 0–15ng/mL); carcinoembryonic antigen (CEA),
1.26ng/mL (normal range, 0–5ng/mL); carcinoma antigen (CA)
19-9, 5.6U/mL (normal range, 50.1–27U/mL). A chest x-ray
showed bilaterally patchy inﬁltrates, increased bronchovascular
markings and mass in the right lower lung ﬁelds (Fig. 1A), which
needed further computerized tomography (CT) detection sug-
gested by radiologists. A plain x-ray of the abdomen showed the
gaseous distention of the bowel with air-ﬂuid levels (Fig. 1B).
Abdominal gaseous echoes were detected by ultrasonography.
CT scans of the chest showed bilateral upper-lobe with patchy
inﬁltrates, focal calciﬁcation and nodular opacities peripherally
with cavitation, which indicated the changes of post-primary
pulmonary tuberculosis (Fig. 2A); CT scans of the abdomen
showed air-ﬂuid levels in loops of small bowel, which indicated
that mechanical obstruction was a likely diagnosis (Fig. 2B).
Pathologic consultation of gastroscopic biopsy specimens in our
hospital conﬁrmed the diagnosis of squamous-cell carcinoma.
Given the rarity of gastric squamous-cell carcinoma, pathologists
suggested that further examination was needed to ﬁnd the
primary tumor. An enhanced CT scan was performed in this
condition and the results were shown that the enhancement ofFigure 1. Plain x-rays of chest and abdomen on hospital admission. (A) Chest x-ray
mass in the right lower lung ﬁelds. (B) Abdomen x-ray showing showed the gase
2right lower lung ﬁelds was not evident, which implied lung
sclerosis after tuberculosis (Fig. 3).
OnMarch 5, 2014, the suddenly occurred abdominal pain was
persistent and severe. The diagnosis of acute abdomen was made
and urgent surgery was needed. The patient underwent a
laparotomy with curative gastrectomy for gastric cancer and
small bowel partial resection. Intraoperatively, a mass with a
diameter of 0.8cm was palpable in the greater curvature of the
stomach and there was no signiﬁcant lymphadenopathy (Fig. 4A,
B). In addition, a mass with a diameter of 3cm was found in the
small bowel at the distance of approximately 30cm to ileocecal
area and the bowel became completely obstructed (Fig. 4C, D).
Postoperative histopathology conﬁrmed a moderately-differenti-
ated squamous-cell carcinoma with full-thickness inﬁltration and
vessel invasion in stomach (Fig. 5A, B) and small bowl (Fig. 5C,
D). The margins of resection were free of tumor in the specimens
and no regional lymph node metastasis was found in perigastric
and perienteric area. In view of the rareness of gastrointestinal
multiple primary squamous-cell carcinoma, further research was
recommended by pathologists to exclude the metastatic squa-
mous-cell carcinoma from the lung or the esophagus.
Esophageal mass or lesion was not found on endoscopic
examination and the metastatic squamous-cell carcinoma from
the esophagus was excluded. It was important to attempt to
isolate the tumor cells from the sputum and to carry out a lung
biopsy. In the ﬁfth examination of stained smears of sputum,
squamous-cells with properties of tumor cells were found.
Meanwhile, transbronchial aspirates were obtained with a 19-
gauge ﬂexible histology needle by using a CT scan as a guide and
squamous-cell lung cancer was conﬁrmed (Fig. 6A, B).
The diagnosis of lung squamous-cell carcinoma with multiple
metastases to the stomach and small bowl was conﬁrmed. As the
tumor was not resectable, surgeons recommended conservative
treatments. The patient was recommended with combination
chemotherapy of carboplatin and paclitaxel for 3 cycles.
However, in September 2014, the patient succumbed to
respiratory failure.
3. Discussion
The clinical incidence of gastrointestinal metastasis of lung
cancer has been reported to be as low as 0.2% to 1.7%.[7,8]
However, autopsy disclosed 4.7% to 14.0% gastrointestinal
metastasis of primary lung cancer.[9,10] Most commonly, the
clinical course of gastrointestinal metastasis of primary lungshowing bilaterally patchy inﬁltrates, increased bronchovascular markings, and
ous distention of the bowel with air-ﬂuid levels.
Figure 2. CT scans of chest and abdomen on hospital admission. (A) CT scans of the chest showed bilateral upper-lobe with patchy inﬁltrates, focal calciﬁcation,
and nodular opacities peripherally with cavitation. (B) CT scans of the abdomen showed air-ﬂuid levels in loops of small bowel.
Li et al. Medicine (2018) 97:24 www.md-journal.comcancer is insidious, which make it difﬁcult to diagnose especially
in the early stage. In the current study, the patient was diagnosed
with gastrointestinal multiple metastases of squamous-cell lung
cancer, which has not been reported by other studies.
Symptomaticmetastatic gastrointestinal lesions from lung cancer
are rare and the majority of symptoms caused by metastatic
gastrointestinal carcinoma are not noticeable, including weight
loss, abdominal pain, meteorism, and constipation.[11,12] The3clinical diagnosis of metastatic gastrointestinal tumors is
difﬁcult. Gastrointestinal endoscopy and histopathologic diag-
nosis are the gold standard for metastatic gastrointestinal
tumors. Some clinical studies have shown that adenocarcinoma
of lung cancer is more likely to metastasize to gastrointestinal
tract.[9] In the current study, doctors ﬁrstly found the metastatic
tumor in gastrointestinal tract and ﬁnally conﬁrmed the primary
lung squamous-cell carcinoma. Prior tuberculosis increased the
Figure 3. An enhanced CT scan showing that the enhancement of right lower lung ﬁelds was not evident.
Li et al. Medicine (2018) 97:24 Medicinedifﬁculty of clinical diagnostic procedures of lung cancer in this
patient.
Gastrointestinal endoscopy is an accurate method of identify-
ing patients with gastric, duodenal, or colonic metastatic tumors
from lung cancer.[7] However, gastrointestinal endoscopy cannot
reach small bowl and capsule endoscopy is a good substitute. CT
is one of the most commonly offered by clinical doctors as an
estimate of metastasis tumors from the lung. Gastrointestinal
metastasis from lung cancer should be considered in the
differential diagnosis when CT scans depict short segmentalFigure 4. The images of intraoperative view and surgically removed specimens. (A,
stomach. (C, -D) A mass with a diameter of 3cm was found in the small bowel.
4bowel-wall thickening or a polypoid mass in the small intestine in
combination with regional lymphadenopathy, perforation, or
intussusception.[8] In addition, PET-CT scanning has good
sensitivity and speciﬁcity to detect metastatic tumors, which is
recommended in hospitals available.[13–15] Imaging of the lung is
critical for diagnostic decision-making and radiographic char-
acteristics in this patient were masked by sclerosis after
tuberculosis.
Histological type of gastrointestinal metastatic lung cancer was
squamous-cell carcinoma in the current study, and some clinicalB) Amass with a diameter of 0.8cmwas palpable in the greater curvature of the
Figure 5. The images of postoperative histopathology. (A, B) Images for gastric slices showing a moderately-differentiated squamous-cell carcinoma. (C, D)
Images for slices of small bowl showing amoderately-differentiated squamous-cell carcinoma. A and Cwere observed under200 light microscope; B and Dwere
observed under 400 light microscope.
Li et al. Medicine (2018) 97:24 www.md-journal.comstudies have demonstrated that squamous-cell carcinoma, large
cell carcinoma, and pleomorphic carcinoma of lung cancer are
more frequent to metastasize to gastrointestinal tracts.[16,17]
However, other certain studies and autopsy series have shown
adenocarcinoma to be prominent.[18,19] Therefore, the histologi-
cal type predominantly associated with gastrointestinal metasta-
sis remains incompletely understood. Immunohistochemical
techniques provide an improved method to distinction of the
primary source of gastrointestinal metastatic tumors. Immuno-
staining with TTF-1, CDX2, CK7, and CK20 is helpful in
highlighting lung primary.[11,20]
The method underlying the spread of metastasis from lung
cancer to the intra-abdominal region is believed to involve
hematogenous and lymphatic routes.[21,22] The dissemination of
cancer cells from the lung through the blood to new organ sites.Figure 6. The images of needle biopsy histopathology were shown in (A, B) and
microscope; B was observed under 400 light microscope.
5However, seedling metastasis cannot be ignored in the process of
gastrointestinal metastasis. Tumor cells may be swallowed
through sputum and induce gastrointestinal seeding. An
important future step is needed to clarify the mechanistic details
that tumor cells tolerate the nonimmune defense gastric acidity.
In the present study, the patient had gastrointestinal multiple
metastases of lung cancer and squamous-cells with properties of
tumor cells were found in the examination of stained smears of
sputum, which may indicate the sputum seedling metastasis
hypothesis. However, the mechanism of such hypothesis still
remains to be investigated.
Most lung cancer patients with gastrointestinal metastasis
exhibit bowel perforation or an acute abdomen. Surgical
management should be considered as palliative treatment in
patients with bowel obstruction or peritonitis caused by primarysquamous-cell lung cancer was conﬁrmed. A was observed under 200 light
[7,10] [5] Miyazaki J, Hirota S, Abe T. Metastasis of lung cancer to the
Li et al. Medicine (2018) 97:24 Medicinelung cancer. Postoperative chemotherapy and individualized
treatment may improve the survival rate for these lung cancer
patients. Some studies have shown that there was no signiﬁcant
difference in recurrence-free survival between patients with
metastasis treated with postoperative adjuvant chemotherapy
and chemoradiotherapy.[23] In addition, vascular-targeted thera-
py has gradually been accepted in recent years. Vascular
endothelial growth factor-positive patients may beneﬁt more
from bevacizumab treatment.[24] Previous studies have shown
that the time interval between diagnosis of the primary tumor and
manifestation of gastrointestinal metastasis ranged between 2
week and 4 years and the mean time between the identiﬁcation of
the gastrointestinal metastasis and mortality was 100.6
days.[18,25] Because of the poor survival of the majority of
patients, the early diagnosis and the development of novel
systemic therapies for gastrointestinal metastasis of lung cancer
are of paramount importance.
In conclusion, gastrointestinal multiple metastases of lung
cancer are extremely rare. The majority of gastrointestinal
metastasis cases are diagnosed at a late stage. Despite newer
methodology in treatment of this condition, the prognosis still
remains poor. Therefore, the presence of clinical gastrointestinal
metastasis may be life threatening and comprehensive evaluations
are required to detect and monitor gastrointestinal metastasis
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